11011-72-6|Bluensomycin|[(1S,2S,3S,4S,5R,6R)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl] carbamate|-范德生物科技公司

Bluensomycin

NMR下载 COA and HPLC MSDS下载
names：
[(1S,2S,3S,4S,5R,6R)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl] carbamate
CAS号：
11011-72-6
MDL Number：
MF(分子式)： C21H39N5O14 MW(分子量)： 585.564
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)
FMK12762-100mg	100mg	>98%	¥ 0.00	¥ 0.00		Get quote	- +	¥ 0.00

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Bluensomycin
英文别名	Bluensomycin; U 12898; U12898; U-12898
CAS号	11011-72-6
Inchi	InChI=1S/C21H39N5O14/c1-5-21(35,4-28)16(40-17-8(25-2)10(30)9(29)6(3-27)37-17)18(36-5)38-14-7(26-19(22)23)11(31)15(39-20(24)34)13(33)12(14)32/h5-18,25,27-33,35H,3-4H2,1-2H3,(H2,24,34)(H4,22,23,26)/t5-,6-,7-,8-,9-,10-,11-,12+,13+,14-,15-,16-,17-,18-,21+/m0/s1
InchiKey	RQLDKUSQKQMFCN-DOOXDOMHSA-N
分子式 Formula	C21H39N5O14
分子量 Molecular Weight	585.564
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Bluensomycin(CAS:11011-72-6):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Bluensomycin is a a broad spectrum antibiotic similar to streptomycin that has been found effective against Staphylococcus and Proteus bacteria.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Ray BJ, Pittillo RF. Chemotherapeutic activity of bluensomycin. Appl Microbiol. 1969 Sep;18(3):509-10. PubMed PMID: 5373681; PubMed Central PMCID: PMC378014.

[2]Walker JB. Possible evolutionary relationships between streptomycin and bluensomycin biosynthetic pathways: detection of novel inositol kinase and O-carbamoyltransferase activities. J Bacteriol. 1990 Oct;172(10):5844-51. PubMed PMID: 1698764; PubMed Central PMCID: PMC526902.

[3] Jung YG, Kang SH, Hyun CG, Yang YY, Kang CM, Suh JW. Isolation and characterization of bluensomycin biosynthetic genes from Streptomyces bluensis. FEMS Microbiol Lett. 2003 Feb 28;219(2):285-9. PubMed PMID: 12620633.

[4] Walker JB. Pathways of biosynthesis of the guanidinated inositol moieties of streptomycin and bluensomycin. Methods Enzymol. 1975;4

[5]429-33. PubMed PMID: 48996.

5: Wallace ST, Schroeder R. In vitro selection and characterization of streptomycin-binding RNAs: recognition discrimination between antibiotics. RNA. 1998 Jan;4(1):112-23. PubMed PMID: 9436913; PubMed Central PMCID: PMC1369601.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开